| related words |
| corlux |
| orphan |
| protein |
| stent |
| marketed |
| recothrom |
| nexavar |
| novel |
| soliris |
| designation |
| promoting |
| therapy |
| feraheme |
| tarceva |
| gene |
| artefill |
| asserted |
| labcorp |
| zegerid |
| version |
|
| related documents |
| 1097264--3/1/2010--ALLOS_THERAPEUTICS_INC |
| 1097264--3/3/2009--ALLOS_THERAPEUTICS_INC |
| 1047188--3/16/2010--PENWEST_PHARMACEUTICALS_CO |
| 1178879--3/10/2010--AMICUS_THERAPEUTICS_INC |
| 1367644--3/6/2009--Emergent_BioSolutions_Inc. |
| 1013238--3/30/2009--ARADIGM_CORP |
| 707511--3/28/2008--REGENERX_BIOPHARMACEUTICALS_INC |
| 1367644--3/10/2008--Emergent_BioSolutions_Inc. |
| 1013238--3/27/2008--ARADIGM_CORP |
| 1178879--2/8/2008--AMICUS_THERAPEUTICS_INC |
| 1367644--3/27/2007--Emergent_BioSolutions_Inc. |
| 1013238--3/30/2007--ARADIGM_CORP |
| 1097264--3/14/2007--ALLOS_THERAPEUTICS_INC |
| 730272--6/10/2010--REPLIGEN_CORP |
| 1385830--3/19/2010--NeurogesX_Inc |
| 1262175--3/9/2007--TERCICA_INC |
| 902622--3/6/2007--ICAGEN_INC |
| 1310094--12/29/2006--ACCENTIA_BIOPHARMACEUTICALS_INC |
| 1262175--3/16/2006--TERCICA_INC |
| 902622--3/15/2006--ICAGEN_INC |
|
| related topics |
| {product, liability, claim} |
| {property, intellectual, protect} |
| {product, candidate, development} |
| {investment, property, distribution} |
| {capital, credit, financial} |
| {operation, natural, condition} |
| {customer, product, revenue} |
| {product, market, service} |
| {system, service, information} |
| {loan, real, estate} |
| {cost, contract, operation} |
| {financial, litigation, operation} |
| {loss, insurance, financial} |
| {personnel, key, retain} |
| {cost, operation, labor} |
| {control, financial, internal} |
| {acquisition, growth, future} |
| {operation, international, foreign} |
| {gas, price, oil} |
| {cost, regulation, environmental} |
|